AstraZeneca Pharma India Ltd has received clearance from the Central Drugs StandardControl Organisation (CSDCO) to import, sell, and distribute its cancer treatment drug,Lynparza (Olaparib). The medication, available in 100 mg and 150 mg film-coated tablets,
Read More
A recent report by Medi Assist and Boston Consulting Group (BCG) reveals an 8.3% rise inrespiratory health claims in Delhi from FY23 to FY25. This increase aligns with a consistentannual growth rate of 10-12% in
Read More
India’s ship recycling industry holds significant potential for reducing emissions in the steelsector, according to a report by the Climate Group and PwC. As the global leader in shiprecycling, India handles nearly one-third of the
Read More
S&P Global Ratings has adjusted its economic growth forecasts for India, maintaining itsFY25 GDP growth estimate at 6.8% but revising projections for FY26 and FY27 downwardby 20 basis points to 6.7% and 6.8%, respectively.The agency
Read More
The Industrial Review is a beacon of recognition, spotlighting unsung heroes in the Indian business landscape. We address an acknowledgment deficit by championing excellence and inspiring recognition. Join us in rewriting the narrative of success, one achievement at a time.
General: info@theindustrialreview.com
tel: +91 84313 13579
